846 A new case series of olmsted syndrome subjects confirms EGFR activation and long term efficacity of oral erlotinib with acceptable tolerance. Journal of Investigative Dermatology 2022 https://researcherprofiles.org/profile/344527382 J. Basset, Y. Diab, F. Santiago, L. Azulay, K. Cordoro, A. Zhang, F. Watanabe, A. Kirkorian, F. Frascari, D. Siegel, E. Bourrat, R. Howard, A. Hovnanian
